MedTrace Logo

Markers of Response to Intravesical Bladder Cancer Therapy

NCT01007058 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2016-12-07

No results posted yet for this study

Summary

The goal of this laboratory research study is to see if researchers can predict whose cancer will stay in remission and whose will return in patients receiving treatment for bladder cancer.

Conditions

Sponsors & Collaborators

  • Flight Attendant Medical Research Institute

    collaborator OTHER

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Ashish M. Kamat, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01007058 on ClinicalTrials.gov